|
Treatment
|
Tumor size (mm3)
|
|---|
|
Day 0
|
Day 14
|
ΔT/ΔC (%)
|
% Inhibition
|
|---|
|
Control
|
69.0 ± 2.2
|
585.0 ± 40.8
|
100
|
0
|
|
Commercial L-asparaginase
|
67.0 ± 4.5
|
240.7 ± 9.4*
|
33
|
67
|
|
Streptomyces brollosae NEAE-115 L-asparaginase
|
77.6 ± 3.7
|
188.3 ± 8.33$
|
21
|
79
|
- Data are expressed as mean ± SEM, n = 6
- * Significantly different from control group using One-Way ANOVA followed by Tukey-Kramer multiple comparisons test (P < 0.05). $ Significantly different from commercial L-asparaginase-treated group using One-Way ANOVA followed by Tukey-Kramer multiple comparisons test (P < 0.05). Mann-Whitney U test, *P < 0.05
